Linxian Shan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Linxian Shan has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Jun He
College of Food Science and Technology, Yunnan Agricultural University, Kunming 650201, China
2 shared publications - Ruijuan Yang
College of Food Science and Technology, Yunnan Agricultural University, Kunming 650201, China
2 shared publications - Xiaocui Du
College of Agronomy and Biotechnology, Yunnan Agricultural University, Kunming 650201, China
2 shared publications - Yan Shen
College of Food Science and Technology, Yunnan Agricultural University, Kunming 650201, China
2 shared publications - Zezhu Du
College of Food Science and Technology, Yunnan Agricultural University, Kunming 650201, China
2 shared publications - Chongye Fang
College of Food Science and Technology, Yunnan Agricultural University, Kunming, China
1 shared publication
Latest Publications
- Open Access
Structural Insights and Metabolic Profiles of Oxidized Green Coffee Extract, and Its Impact on Obesity and Gut Microbiota in High-Fat Diet-Fed Mice
Background: Obesity is a severe chronic disease impacting health, closely linked to intestinal microbiota. Gut microbiome significantly contributes to obesity and metabolic issues. This study aims to explore the structural characterization of two coffee extracts and their effects on gut microbiota disturbances caused by a high-fat diet (HFD). Methods: Male C57BL/6J mice were divided into four groups—normal diet (ND), high-fat diet (HFD), HFD supplemented with unroasted coffee extract (UC), and HFD supplemented with oxidized green coffee extract (GCE). Results: Structural characterization revealed that both extracts are polymeric phenolic compounds rich in hydroxyl and carboxyl groups. Full-target metabolomic analysis revealed significant metabolic differences between the extracts, with 499 differential metabolites identified: a total of 247 metabolites were upregulated and 252 were downregulated in GCE compared to UC. Supplementation with GCE reduced body weight gain and adipose tissue accumulation, improved dyslipidemia and insulin sensitivity, and enhanced hepatic antioxidant capacity in high-fat model mice. Gut microbial analysis showed that GCE significantly (p < 0.05) increased the growth of beneficial bacteria such as Prevotella, Butyricimonas, and Parabacteroides. Conclusions: Oxidized green coffee extract has the effect of lowering lipids and increasing intestinal beneficial bacteria.
Open AccessStructural Insights and Metabolic Profiles of Oxidized Green Coffee Extract, and Its Impact on Obesity and Gut Microbiota in High-Fat Diet-Fed Mice
Background: Obesity is a severe chronic disease impacting health, closely linked to intestinal microbiota. Gut microbiome significantly contributes to obesity and metabolic issues. This study aims to explore the structural characterization of two coffee extracts and their effects on gut microbiota disturbances caused by a high-fat diet (HFD). Methods: Male C57BL/6J mice were divided into four groups—normal diet (ND), high-fat diet (HFD), HFD supplemented with unroasted coffee extract (UC), and HFD supplemented with oxidized green coffee extract (GCE). Results: Structural characterization revealed that both extracts are polymeric phenolic compounds rich in hydroxyl and carboxyl groups. Full-target metabolomic analysis revealed significant metabolic differences between the extracts, with 499 differential metabolites identified: a total of 247 metabolites were upregulated and 252 were downregulated in GCE compared to UC. Supplementation with GCE reduced body weight gain and adipose tissue accumulation, improved dyslipidemia and insulin sensitivity, and enhanced hepatic antioxidant capacity in high-fat model mice. Gut microbial analysis showed that GCE significantly (p < 0.05) increased the growth of beneficial bacteria such as Prevotella, Butyricimonas, and Parabacteroides. Conclusions: Oxidized green coffee extract has the effect of lowering lipids and increasing intestinal beneficial bacteria.
- Open Access
Coral dealbatus Crude Polysaccharide Attenuates Fat Accumulation and Intestinal Flora Disorders in Mice Fed with a High-Fat Diet
Obesity, a major risk factor for cardiometabolic diseases, arises from chronic energy imbalance and ectopic lipid deposition. This study investigated the anti-obesity potential of Coral dealbatus crude polysaccharides (CDP), a previously uncharacterized bioactive fraction from a hybrid vegetable cultivar developed by the Chinese Academy of Agricultural Sciences. CDP, obtained via hydroalcoholic extraction, was structurally characterized as amorphous with heterogeneous molecular weights (87,813 Da, 4158 Da, and 728 Da) and glucose-dominant monosaccharide composition (FT-IR, XRD, and HPLC). In a high-fat diet (HFD)-induced murine obesity model, oral CDP administration significantly attenuated body weight gain (p < 0.05) and reduced ectopic lipid deposition. Histopathological analysis confirmed CDP’s efficacy in ameliorating hepatic steatosis, evidenced by diminished lipid droplet accumulation. Furthermore, CDP reversed HFD-induced gut microbiota dysbiosis, modulating beneficial bacterial taxa. These findings demonstrate CDP’s therapeutic potential against diet-induced metabolic disorders, likely mediated through lipid metabolism regulation and intestinal microbiota modulation, supporting its development as a novel functional food ingredient for dietary intervention.
Open AccessCoral dealbatus Crude Polysaccharide Attenuates Fat Accumulation and Intestinal Flora Disorders in Mice Fed with a High-Fat Diet
Obesity, a major risk factor for cardiometabolic diseases, arises from chronic energy imbalance and ectopic lipid deposition. This study investigated the anti-obesity potential of Coral dealbatus crude polysaccharides (CDP), a previously uncharacterized bioactive fraction from a hybrid vegetable cultivar developed by the Chinese Academy of Agricultural Sciences. CDP, obtained via hydroalcoholic extraction, was structurally characterized as amorphous with heterogeneous molecular weights (87,813 Da, 4158 Da, and 728 Da) and glucose-dominant monosaccharide composition (FT-IR, XRD, and HPLC). In a high-fat diet (HFD)-induced murine obesity model, oral CDP administration significantly attenuated body weight gain (p < 0.05) and reduced ectopic lipid deposition. Histopathological analysis confirmed CDP’s efficacy in ameliorating hepatic steatosis, evidenced by diminished lipid droplet accumulation. Furthermore, CDP reversed HFD-induced gut microbiota dysbiosis, modulating beneficial bacterial taxa. These findings demonstrate CDP’s therapeutic potential against diet-induced metabolic disorders, likely mediated through lipid metabolism regulation and intestinal microbiota modulation, supporting its development as a novel functional food ingredient for dietary intervention.